ORYZON Announces New Senior VP of Clinical Development and Global Medical Affairs, Continuing its Expansion of US Corporate Activities

NASDAQ Market News

NEXT STORY
Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones
PREV STORY
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Rare Disease Diagnostics Market: Focus on Disease, Trait Type, Products, Age Group, Test Type, Technology, End User, Country Data (15 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030

author_avatar
NASDAQ Market News

Aptose To Release Second Quarter Ended June 30, 2017 Financial Results and Hold Conference Call on August 8, 2017

SAN DIEGO and TORONTO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) ...

author_avatar
NASDAQ Market News

Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences

author_avatar
NASDAQ Market News